Chiron Capital Management, LLC Precigen, Inc. Transaction History
Chiron Capital Management, LLC
- $111 Million
- Q3 2024
A detailed history of Chiron Capital Management, LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Chiron Capital Management, LLC holds 17,550 shares of PGEN stock, worth $16,146. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,550
Previous 27,850
36.98%
Holding current value
$16,146
Previous $44,000
63.64%
% of portfolio
0.01%
Previous 0.04%
Shares
17 transactions
Others Institutions Holding PGEN
# of Institutions
142Shares Held
148MCall Options Held
292KPut Options Held
53.8K-
Third Security, LLC83.5MShares$76.8 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.9MShares$16.5 Million0.92% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10.9MShares$10 Million0.02% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$9.43 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.33MShares$7.66 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $191M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...